This website contains information about research chemicals for laboratory research only. You must be 18 or over to enter.
By entering you confirm you are 18 or over and that all products are purchased for research purposes only. Not for human consumption.
You must be 18 or over to access this site.
Pre-made research pens · 99%+ purity · batch tested · COA includedPlain-English guides to research peptides. What the science actually shows, where the evidence gaps are, and what it means in practice.
Head-to-head comparison from the SURMOUNT-5 trial. Why GDmounjaro produced 47% greater weight loss than semaglutide and what the dual mechanism means.
Read article →GDreta targets three receptors simultaneously. Phase 3 data shows 30% average weight loss — approaching bariatric surgery numbers. How it works and what the trials showed.
Read article →GDmounjaro, GDreta, tesamorelin, Lemon Bottle — what each one does, how it works differently, and what the evidence standard is for each.
Read article →Two complementary tissue repair mechanisms that cover more ground together than either alone. The most researched recovery peptide combination available.
Read article →The most evidence-backed peptide for skin health. What the controlled human trials show about collagen, firmness and wound healing — not marketing claims.
Read article →NAD+ drops 50% between 40 and 60. What happens when you restore it — energy, DNA repair, sirtuin activation, and where the evidence gaps remain.
Read article →40 years of Russian research on telomerase activation. Cell studies, animal data, and the honest limitations of the human evidence.
Read article →On Russia's essential medicines list for two decades. BDNF upregulation, dopamine modulation, and why the nasal route matters for brain-targeted peptides.
Read article →Encoded in mitochondrial DNA, not nuclear DNA. How MOTS-c drives metabolism and exercise capacity, and why its age-related decline matters.
Read article →Phase 2 and 3 human trials across multiple conditions. How it stabilises the mitochondrial membrane and what the clinical outcomes actually showed.
Read article →FDA-approved. Targets visceral abdominal fat specifically through a GHRH mechanism. Phase 3 data showed 15-20% reductions in visceral fat.
Read article →Two completely separate receptor pathways targeting the same outcome. Why the combination produces synergistic GH pulses and what selectivity means for Ipamorelin.
Read article →NF-κB inhibition, gut tissue specificity via PepT1, and why it appears in the KLOW and Glow Stack. What the cell and animal evidence shows.
Read article →Why complementary mechanisms matter. The logic behind each of the 10 G&D Pharma stacks and what makes some combinations more effective than others.
Read article →New to research peptides? What they are, how they differ from proteins, why injection is necessary, and how they interact with receptors to produce biological effects.
Read article →